Jaspaul S Jawanda, MD | |
35 Memorial Dr, Pinehurst, NC 28374-8708 | |
(910) 715-5481 | |
(910) 715-5745 |
Full Name | Jaspaul S Jawanda |
---|---|
Gender | Male |
Speciality | Infectious Disease |
Experience | 25 Years |
Location | 35 Memorial Dr, Pinehurst, North Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1174579726 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RI0200X | Internal Medicine - Infectious Disease | 200201265 (North Carolina) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Firsthealth Moore Regional Hospital | Pinehurst, NC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Firsthealth Of The Carolinas Inc | 8820909377 | 110 |
News Archive
Modern Healthcare's 2010 list of the sector's most powerful players is out, and because of the health law, regulators in usually lower-profile federal agencies have carved out places near the top of the roster for the second year in a row. The magazine reports, "Carolyn Clancy, director of the Agency for Healthcare Research and Quality, stood at No. 31 on the list three years ago. This year, just as in 2009, she holds the No. 7 spot. Clancy's clout has risen with the agency, which was created 20 years ago to support and conduct healthcare outcomes research."
San Diego County, battling a deadly outbreak of hepatitis A, is postponing an outreach campaign to provide the second of two inoculations against the contagious liver disease until a national shortage of the vaccine is resolved, the county's chief public health officer said.
Innoheart and genae today announced a shared vision on integrated research services, allowing the acceleration of clinical research and development of biomedical devices and therapies. The alliance will allow both organizations to drive new growth opportunities globally and transform translational clinical research, reducing costs and accelerating market entry for new biomedical devices and therapies.
Advanced non-small cell lung cancer (NSCLC) patients have few effective treatment options and low 5-year survival rates. The checkpoint inhibitors MEDI4736 and tremelimumab have both demonstrated acceptable safety and potential efficacy when used as single-agents in several different types of cancer.
› Verified 7 days ago
Entity Name | Firsthealth Of The Carolinas Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1548276389 PECOS PAC ID: 8820909377 Enrollment ID: O20031108000016 |
News Archive
Modern Healthcare's 2010 list of the sector's most powerful players is out, and because of the health law, regulators in usually lower-profile federal agencies have carved out places near the top of the roster for the second year in a row. The magazine reports, "Carolyn Clancy, director of the Agency for Healthcare Research and Quality, stood at No. 31 on the list three years ago. This year, just as in 2009, she holds the No. 7 spot. Clancy's clout has risen with the agency, which was created 20 years ago to support and conduct healthcare outcomes research."
San Diego County, battling a deadly outbreak of hepatitis A, is postponing an outreach campaign to provide the second of two inoculations against the contagious liver disease until a national shortage of the vaccine is resolved, the county's chief public health officer said.
Innoheart and genae today announced a shared vision on integrated research services, allowing the acceleration of clinical research and development of biomedical devices and therapies. The alliance will allow both organizations to drive new growth opportunities globally and transform translational clinical research, reducing costs and accelerating market entry for new biomedical devices and therapies.
Advanced non-small cell lung cancer (NSCLC) patients have few effective treatment options and low 5-year survival rates. The checkpoint inhibitors MEDI4736 and tremelimumab have both demonstrated acceptable safety and potential efficacy when used as single-agents in several different types of cancer.
› Verified 7 days ago
Entity Name | Mcpc-23 Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1669123931 PECOS PAC ID: 6002292513 Enrollment ID: O20221007000114 |
News Archive
Modern Healthcare's 2010 list of the sector's most powerful players is out, and because of the health law, regulators in usually lower-profile federal agencies have carved out places near the top of the roster for the second year in a row. The magazine reports, "Carolyn Clancy, director of the Agency for Healthcare Research and Quality, stood at No. 31 on the list three years ago. This year, just as in 2009, she holds the No. 7 spot. Clancy's clout has risen with the agency, which was created 20 years ago to support and conduct healthcare outcomes research."
San Diego County, battling a deadly outbreak of hepatitis A, is postponing an outreach campaign to provide the second of two inoculations against the contagious liver disease until a national shortage of the vaccine is resolved, the county's chief public health officer said.
Innoheart and genae today announced a shared vision on integrated research services, allowing the acceleration of clinical research and development of biomedical devices and therapies. The alliance will allow both organizations to drive new growth opportunities globally and transform translational clinical research, reducing costs and accelerating market entry for new biomedical devices and therapies.
Advanced non-small cell lung cancer (NSCLC) patients have few effective treatment options and low 5-year survival rates. The checkpoint inhibitors MEDI4736 and tremelimumab have both demonstrated acceptable safety and potential efficacy when used as single-agents in several different types of cancer.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Jaspaul S Jawanda, MD Po Box 843026, Boston, MA 02284-3026 Ph: (910) 715-5481 | Jaspaul S Jawanda, MD 35 Memorial Dr, Pinehurst, NC 28374-8708 Ph: (910) 715-5481 |
News Archive
Modern Healthcare's 2010 list of the sector's most powerful players is out, and because of the health law, regulators in usually lower-profile federal agencies have carved out places near the top of the roster for the second year in a row. The magazine reports, "Carolyn Clancy, director of the Agency for Healthcare Research and Quality, stood at No. 31 on the list three years ago. This year, just as in 2009, she holds the No. 7 spot. Clancy's clout has risen with the agency, which was created 20 years ago to support and conduct healthcare outcomes research."
San Diego County, battling a deadly outbreak of hepatitis A, is postponing an outreach campaign to provide the second of two inoculations against the contagious liver disease until a national shortage of the vaccine is resolved, the county's chief public health officer said.
Innoheart and genae today announced a shared vision on integrated research services, allowing the acceleration of clinical research and development of biomedical devices and therapies. The alliance will allow both organizations to drive new growth opportunities globally and transform translational clinical research, reducing costs and accelerating market entry for new biomedical devices and therapies.
Advanced non-small cell lung cancer (NSCLC) patients have few effective treatment options and low 5-year survival rates. The checkpoint inhibitors MEDI4736 and tremelimumab have both demonstrated acceptable safety and potential efficacy when used as single-agents in several different types of cancer.
› Verified 7 days ago
Michael A Pritchett, D.O. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 205 Page Road, Pinehurst, NC 28374 Phone: 910-295-9359 Fax: 910-235-3401 | |
Bobby R Maynor Jr., MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 15 Regional Dr, Pinehurst, NC 28374 Phone: 910-255-4400 Fax: 910-420-1604 | |
Francis Farrell Collins Jr., MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 205 Page Rd, Pinehurst, NC 28374 Phone: 910-295-9359 Fax: 910-235-3419 | |
Kristina Maria Catania, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 155 Memorial Dr, Pinehurst, NC 28374 Phone: 910-715-7984 | |
Dr. Scott D Skibo, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 205 Page Rd, Pinehurst, NC 28374 Phone: 102-955-5119 Fax: 910-235-3421 | |
David F Martin, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 15 Regional Dr, Pinehurst, NC 28374 Phone: 910-295-9207 Fax: 910-235-3432 | |
Charles Samuel Kuzma, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 220 Page Rd, Pinehurst, NC 28374 Phone: 910-715-3500 Fax: 910-715-3501 |